Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNordlandssykehuset HF

About this trial

The main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria).

Aim: Investigate the diet's impact on tissue and serum glucose, plasma insulin, cytokine levels, amino acids, and gut microbiota in AIP, and their correlation with PBG (Porphobilinogen).

Aim: Assess the diet's effect on AIP symptoms and health status in AIP. Aim: Measure the effect of a high-carbohydrate diet on mitochondrial activity in AIP Aim: Map and detect potential mutations in mitochondrial genomic DNA in AIP Aim: Discover new markers in AIP through RNA sequencing and machine learning.

Participants will follow two diet plans, a 4-week intervention with 60-65 E% carbohydrates and a 4 week intervention with 40-45 E% carbohydrates.

Eligibility criteria

Qualifiers

Diagnosis of AIP

Disqualifiers

Not having diagnosis of AIP

Undergoing treatment as part of other clinical research on AIP

Pregnancy

Diabetes

Trial design

Treatments tested in this trial

  • Carbohydrates

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Nordlandssykehuset HF

Lead sponsor

University of Oslo

Collaborator

Nord University

Collaborator

UiT The Arctic University of Norway

Collaborator

Norwegian University of Science and Technology

Collaborator

The University of Texas Medical Branch, Galveston

Collaborator

Karolinska University Hospital

Collaborator

University Hospital, Umeå

Collaborator